89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details

臨床試験数 : 38 / 薬物数 : 38 - (DrugBank : 15) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 118

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02484664 (ClinicalTrials.gov)	June 15, 2016	25/6/2015	COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC	COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC	Lymphangioleiomyomatosis (LAM)	Drug: Celecoxib	Brigham and Women's Hospital	National Heart, Lung, and Blood Institute (NHLBI)	Completed	18 Years	70 Years	Female	12	Phase 2	United States